Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: Studies in upper aerodigestive tract cancers

Pharmacogenetics

Volumn 8, Issue 2, 1998, Pages 91-100

  Matthias, Christoph ^a   Bockmühl, Ulrike ^a   Jahnke, Volker ^a   Jones, Peter W ^b   Hayes, John D ^c   Alldersea, Julie ^b   Gilford, Janice ^b   Bailey, Lisa ^b   Bath, Joanna ^b   Worrall, Stephen F ^b   Hand, Philip ^b   Fryer, Anthony A ^b   Strange, Richard C ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cancer susceptibility; Cytochrome P450; Glutathione S transferase; Upper aerodigestive tract cancers

Indexed keywords

DEBRISOQUINE 4 HYDROXYLASE; DIMETHYLNITROSAMINE DEMETHYLASE; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; ISOENZYME;

ADULT; AGED; ALCOHOLISM; ALLELE; ARTICLE; CANCER RISK; CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; SKIN CANCER; SMOKING; SQUAMOUS CELL CARCINOMA;

AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; SMOKING;

EID: 15444355381     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal cancer risk. Cancer Res. 1995; 55:3483-3485.
2. Anttila S, Luostarinen L, Hirvonen A, Elovaara E, Karjalainen A, Nurminen T et al. Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: Association with GSTM1 polymorphism, smoking and asbestos exposure. Cancer Res 1995; 55:3305-3309.
3. Blot WJ, McLaughlin JK, Winn DM. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48:3282-3287.
4. Cascorbi I, Brockmöller J, Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res 1996; 56:4965-4969.
5. Copper MP, Jovanovic A, Nauta JJP, Braakhuis BJM, Vries N, Waal I, Snow GB. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolarynogol 1995; 121:157-160.
6. Doll R, Peto R. Causes of cancer. Oxford: Oxford University Press. 1981.
7. Elexpuru-Camiruaga J, Buxton N, Kandula V, Dias VS, Campbell D, McIntosh J et al. Susceptibility to astrocytoma and meningioma: Influence of allelism at glutathione S-transferase, GSTT1 and GSTM1 and cytochrome P450, CYP2D6 loci. Cancer Res 1995; 55:4237-4239.
8. Flanagan JR. Autologous stimulation of YY1 transcription factor expression-role of an insulin-like growth-factor. Cell Growth Different 1995; 6:85-190.
9. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991; 110:559-565.
10. Heagerty A, Smith A, English J, Lear J, Perkins W, Bowers B, Jones P, Gilford J, Alldersea J, Fryer AA, Strange RC. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. Br J Cancer 1996; 73:44-48.
11. Hirvonen A, Husgafvel-Pursianen K, Karjalainen A, Anttila S, Vainio H. Point-mutational Msp1 and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidem Biomarkers Prevent 1992; 1:485-489.
12. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Vainio H. The human CYP2E1 gene and lung cancer: Dra1 and Rsa1 restriction length polymorphisms in a Finnish study population. Carcinogenesis 1993; 14:85-88.
13. Inskip A, Elexperu-Camiruaga J, Buxton N, Dias PS, MacIntosh J, Campbell D et al. Identification of polymorphism at the glutathione-S-transferase. GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 1995; 312:713-716.
14. Jahnke V. Bōsartige Tumoren des Larynx. In: Naumann HH, Helms J, Herberhold C, Kastenbauer E, eds. Oto-rhino-laryngologie in klinik und praxis, vol. 3: hals. Stuttgart-New York: Georg Thieme Verlag. 1995; 388-421.
15. Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H et al. Cytochrome P450IIE1 Genetic polymorphisms, racial variation and lung cancer risk. Cancer Res 1992; 52:6712-6715.
16. Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995; 16:2331-2336.
17. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer 1995; 75:147-153.
18. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993; 53:2994-2999.
19. Nebert DW. Drug-metabolizing enzymes in ligand-modulated transcription. Biochem Pharm 1994; 47:25-37.
20. Perera FP. Molecular epidemiology: insights into cancer susceptibility, risk assessment and prevention. J Natl Cancer Inst 1996; 88:496-509.
21. Rannug A, Alexandrie A-K, Persson I, Ingelman-Sundberg M. Genetic polymorphism of cytochromes 1A1, 2D6 and 2E1: regulation and toxicological significance. J Occup Environ Med 1995; 37:25-36.
22. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme (s) of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 1990; 11:33-361.
23. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR. Metabolic polymorphisms and cancer susceptibility. Cancer Sun 1995; 25:27-65.
24. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on susceptibility to non-familial cancers. In: Boffetta P, Caporaso N, Cuzick J, Lang M, Vineis P, eds. Metabolic polymorphisms and cancer. Lyon: IARC Scientific Publications, 1998.
25. Uematsu F, Ikwa S, Kikuchi H, Sagami I, Kanamaru R, Abe T et al. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P40IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 1994; 4:58-62.
26. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, Ketterer B et al. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 1994; 15:2841-2845.
27. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A et al. Polymorphism at the glutathione S-transferase, GSTM3 locus: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 1996; 56:1974-1977.